SMARCA4 and lung carcinoma: In particular, SMARCA4, ARID1A, and PBRM1 are lacking in 10% of lung cancer cases, 50% of ovarian clear cell carcinoma cases, and 40% of clear cell renal cell carcinoma cases, respectively (9).